Clinical Trial Update: Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Rocuronium/Org 25969 vs Cisatracurium/Neostigmine in general anesthesia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia-related Conditions

Drugs mentioned

• Cisatracurium (Cisatracurium besylate)
• Neostigmine (neostigmine)
• Org 25969
• Rocuronium (rocuronium bromide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anesthesia, General | Phase 3 | Status: COMPLETED